WealthAi | $1,000,000 | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
Ori Biotech
United Kingdom
- London, England
- 18/01/2022
- Series B
- $100,000,000
Ori Biotech is a London- and New Jersey-based leader in CGT manufacturing technology that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalised, lifesaving treatments.
By fully automating and standardising CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing.
So complex manufacturing challenges can be put where they belong – in the past.
- Industry Automation Machinery Manufacturing
- Website https://oribiotech.com/
- LinkedIn https://www.linkedin.com/company/oribiotech-ltd/about/
Related People
Jason C. FosterFounder
United Kingdom -
London, England
Leveraging my commercial expertise and detailed knowledge of the UK, US and EU healthcare markets, I help build organizations that maximize the value of their products & services to improve health and achieve significant returns for investors.
Mesh Security | $12,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Co-reactive | $7,754,157 | (Jan 30, 2026)
Arkero | $6,000,000 | (Jan 30, 2026)
Redwood Materials | $425,000,000 | (Jan 30, 2026)
Twogee Biotech | $2,575,886 | (Jan 30, 2026)
Levellr | $2,500,000 | (Jan 30, 2026)
Indigo(1) | $50,000,000 | (Jan 30, 2026)
heyData | $16,500,000 | (Jan 30, 2026)